A detailed history of Delta Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Delta Wealth Advisors LLC holds 1,587 shares of ABBV stock, worth $365,803. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,587
Previous 1,688 5.98%
Holding current value
$365,803
Previous $354 Million 16.71%
% of portfolio
0.25%
Previous 0.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Oct 10, 2025

SELL
$170.16 - $206.27 $17,186 - $20,833
-101 Reduced 5.98%
1,587 $295 Million
Q4 2024

Oct 10, 2025

BUY
$164.99 - $203.87 $14,354 - $17,736
87 Added 5.43%
1,688 $300 Million
Q1 2024

Oct 10, 2025

BUY
$159.82 - $182.1 $255,871 - $291,542
1,601 New
1,601 $292 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $408B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Delta Wealth Advisors LLC Portfolio

Follow Delta Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Wealth Advisors LLC with notifications on news.